Efficacy of Postoperative Adjuvant Chemotherapy for Stage II Colon Cancer With High Risk Factors(EPAC1)
Status:
Recruiting
Trial end date:
2024-07-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to design a prospective randomized clinical trial to explore
whether postoperative adjuvant chemotherapy may provide survival benefit for stage II colon
cancer patients with high risk factors.Therefore the investigators can provide high level
clinical evidence of indications for patients with colon cancer with stage II colon cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Beijing Cancer Hospital
Collaborators:
Peking Union Medical College Hospital Peking University People's Hospital